Rite Aid (NYSE:RAD) shares were down today as investors focused on the big year-over-year drop in earnings per share from $0.09 a year ago to $0.04 last quarter.
But smart investors go long term, and Rite Aid reported some more important numbers that relate directly to some of the stock's key growth drivers. In the video below, health care analyst Michael Douglass lays out these three numbers, and what investors should be watching for moving forward.
Leaked: This coming blockbuster could make tons of stocks jealous
The best investors consistently reap gigantic profits by recognizing true potential earlier and more accurately than anyone else. Let me cut right to the chase. There is a product in development that will revolutionize not how we treat a common chronic illness, but potentially the entire health industry. Analysts are already licking their chops at the sales potential. In order to outsmart Wall Street and realize multi-bagger returns you will need The Motley Fool's new free report on the dream-team responsible for this game-changing blockbuster. CLICK HERE NOW.
Michael Douglass has no position in any stocks mentioned. The Motley Fool recommends CVS Caremark. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.